.Merck trumps earnings requirements, raises purchases overview on strong demand for top medicines like Keytruda CNBCMerck & Co. (MRK United States) Defeats Earnings Estimates as Keytruda Sales Surge BloombergMerck Inventory: Pharma Giant Posts Tough Results, Yet Expectation Falls Short Entrepreneur's Organization DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck beats earnings as well as sales requirements amidst Keytruda strength, however gives mixed full-year overview MarketWatch.